Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities
Prestige Consumer Healthcare (NYSE: PBH) has expanded the role of Chief Financial Officer Christine Sacco to include Chief Operating Officer responsibilities, effective immediately. In this enhanced role, Ms. Sacco will oversee the Company's supply chain along with her existing CFO duties. She will continue to report to CEO Ron Lombardi. Lombardi highlighted Sacco's strategic leadership and deep understanding of the business, which have been instrumental in the company's growth over her 8-year tenure as CFO.
Ms. Sacco, a seasoned executive with over 27 years of experience in the consumer products and specialty pharma sectors, has been the CFO since 2016. Her tenure has seen significant contributions to Prestige's strategic transformation and financial success, including strong sales, earnings, and cash flow growth. This expanded role aims to enhance the execution of strategic initiatives and drive operational excellence, positioning Prestige for further organic and M&A growth.
Prestige Consumer Healthcare (NYSE: PBH) ha ampliato il ruolo del Chief Financial Officer Christine Sacco includendo responsabilità di Chief Operating Officer, con effetto immediato. In questo ruolo potenziato, la signora Sacco supervisionerà la catena di approvvigionamento dell'azienda insieme ai suoi attuali doveri di CFO. Continuerà a riportare al CEO Ron Lombardi. Lombardi ha evidenziato la leadership strategica di Sacco e la sua profonda comprensione del business, che sono state strumentali nella crescita dell'azienda durante il suo mandato di 8 anni come CFO.
La signora Sacco, un'esecutiva esperta con oltre 27 anni di esperienza nei settori dei prodotti di consumo e della farmacia specializzata, è CFO dal 2016. Il suo mandato ha portato a contributi significativi alla trasformazione strategica e al successo finanziario di Prestige, inclusi forti vendite, guadagni e crescita del flusso di cassa. Questo ruolo ampliato mira a migliorare l'esecuzione delle iniziative strategiche e a promuovere l'eccellenza operativa, posizionando Prestige per una ulteriore crescita organica e tramite fusioni e acquisizioni.
Prestige Consumer Healthcare (NYSE: PBH) ha ampliado el papel de Chief Financial Officer Christine Sacco para incluir responsabilidades de Chief Operating Officer, con efecto inmediato. En este rol mejorado, la Sra. Sacco supervisará la cadena de suministro de la empresa junto con sus funciones actuales como CFO. Continuará reportando al CEO Ron Lombardi. Lombardi destacó el liderazgo estratégico de Sacco y su profundo entendimiento del negocio, que han sido fundamentales en el crecimiento de la empresa durante sus 8 años como CFO.
La Sra. Sacco, una ejecutiva con más de 27 años de experiencia en los sectores de productos de consumo y farmacia especializada, ha sido CFO desde 2016. Su mandato ha visto contribuciones significativas a la transformación estratégica y al éxito financiero de Prestige, incluyendo un fuerte crecimiento en ventas, ganancias y flujo de caja. Este papel ampliado tiene como objetivo mejorar la ejecución de iniciativas estratégicas y promover la excelencia operativa, posicionando a Prestige para un mayor crecimiento orgánico y a través de fusiones y adquisiciones.
프레스티지 소비자 헬스케어 (NYSE: PBH)는 최고재무책임자 크리스틴 삭코의 역할을 최고운영책임자 책임으로 확대하여 즉시 시행합니다. 이 강화된 역할에서 삭코는 기존 CFO 업무와 함께 회사의 공급망을 감독하게 됩니다. 그녀는 CEO 론 롬바르디에게 계속 보고할 것입니다. 롬바르디는 삭코의 전략적 리더십과 비즈니스에 대한 깊은 이해가 회사의 8년 CFO 임기 동안 성장에 중요한 역할을 했다고 강조했습니다.
삭코는 소비재 및 전문 제약 분야에서 27년 이상의 경력을 가진 경험이 풍부한 임원으로, 2016년부터 CFO로 재직해왔습니다. 그녀의 재직 기간 동안 프레스티지의 전략적 변화와 재무적 성공에 상당한 기여를 했으며, 이는 강력한 매출, 수익 및 현금 흐름 성장으로 이어졌습니다. 이 확장된 역할은 전략적 이니셔티브의 실행을 개선하고 운영 우수성을 높이며, 프레스티지를 더 많은 유기적 성장과 인수 합병 기회에 대비하게 합니다.
Prestige Consumer Healthcare (NYSE: PBH) a élargi le rôle de Chief Financial Officer Christine Sacco pour inclure des responsabilités de Chief Operating Officer, avec effet immédiat. Dans ce rôle renforcé, Mme Sacco supervisera la chaîne d'approvisionnement de l'entreprise, en plus de ses fonctions actuelles de CFO. Elle continuera de rendre compte au CEO Ron Lombardi. Lombardi a souligné le leadership stratégique de Sacco et sa compréhension approfondie de l'entreprise, qui ont été déterminants dans la croissance de l'entreprise durant ses 8 années en tant que CFO.
Mme Sacco, une dirigeante expérimentée avec plus de 27 ans d'expérience dans les secteurs des produits de consommation et de la pharmacie spécialisée, est CFO depuis 2016. Son mandat a vu des contributions significatives à la transformation stratégique et au succès financier de Prestige, y compris une forte croissance des ventes, des bénéfices et des flux de trésorerie. Ce rôle élargi vise à améliorer l'exécution des initiatives stratégiques et à promouvoir l'excellence opérationnelle, positionnant Prestige pour une croissance organique supplémentaire et des fusions et acquisitions.
Prestige Consumer Healthcare (NYSE: PBH) hat die Rolle von Chief Financial Officer Christine Sacco um die Verantwortlichkeiten des Chief Operating Officer erweitert, mit sofortiger Wirkung. In dieser erweiterten Rolle wird Frau Sacco die Lieferkette des Unternehmens überwachen, zusammen mit ihren bestehenden CFO-Aufgaben. Sie wird weiterhin an CEO Ron Lombardi berichten. Lombardi hob die strategische Führung und das tiefgreifende Verständnis des Geschäfts von Sacco hervor, die während ihrer 8-jährigen Amtszeit als CFO entscheidend für das Wachstum des Unternehmens waren.
Frau Sacco, eine erfahrene Führungskraft mit über 27 Jahren Erfahrung in den Bereichen Konsumgüter und Spezialpharma, ist seit 2016 CFO. Ihre Amtszeit beinhaltete bedeutende Beiträge zur strategischen Transformation und finanziellen Erfolg von Prestige, einschließlich eines starken Wachstums bei Umsatz, Gewinn und Cashflow. Diese erweiterte Rolle zielt darauf ab, die Umsetzung strategischer Initiativen zu verbessern und betriebliche Exzellenz voranzutreiben, um Prestige für weiteres organisches Wachstum und Fusionen und Übernahmen zu positionieren.
- Christine Sacco's expanded role to include COO responsibilities aims to enhance operational excellence.
- Under Sacco's financial leadership, Prestige has achieved strong sales, earnings, and cash flow growth.
- The company is positioned with significant future capital allocation flexibility to drive shareholder value.
- None.
TARRYTOWN, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced that Chief Financial Officer Christine Sacco’s responsibilities have been expanded to include the role of Chief Operating Officer, effective immediately. In this enhanced position as COO/CFO, Ms. Sacco will oversee the Company’s supply chain, in addition to her existing responsibilities. Ms. Sacco will continue to report to Ron Lombardi, Chief Executive Officer of Prestige.
“Chris’ strategic leadership and deep understanding of our business has been instrumental in our growth and success over her 8 years as CFO,” said Ron Lombardi. “This expanded COO/CFO role positions us to further enhance execution of our strategic initiatives and drive operational excellence across the organization. Her proven track record in finance combined with her experience working closely with our supply chain operations uniquely positions her to drive further operational excellence and long-term organic and M&A growth for our Company in this expanded role.”
A seasoned executive with more than 27 years of leadership experience in the consumer products and specialty pharma space, Ms. Sacco has served as the Company’s Chief Financial Officer since 2016. During her tenure, she has made vital contributions to the Company’s strategic transformation and financial success. Under her financial leadership, the Company has achieved strong sales, earnings and cash flow growth over the past 8 years while positioning Prestige with significant future capital allocation flexibility to drive further shareholder value.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is a leading consumer healthcare products company with sales throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
Source: Prestige Consumer Healthcare Inc.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b8a99b5b-fd18-4d27-9a39-e14d1986df82
FAQ
What is the significance of Christine Sacco's expanded role at Prestige Consumer Healthcare?
What responsibilities will Christine Sacco have as COO/CFO of Prestige Consumer Healthcare?
How has Christine Sacco contributed to Prestige Consumer Healthcare's success?
What experience does Christine Sacco bring to her new role at Prestige Consumer Healthcare?
What is the impact of Christine Sacco's expanded role on Prestige Consumer Healthcare's strategic initiatives?
